BNP Paribas Exane Issues Positive Forecast for AMETEK (NYSE:AME) Stock Price

AMETEK (NYSE:AME) had its target price increased by equities research analysts at BNP Paribas Exane from $280.00 to $290.00 in a report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the technology company’s stock. BNP Paribas Exane’s price target points to a potential upside of 19.84% from the company’s current price.

Several other research analysts have also commented on the stock. Royal Bank Of Canada lifted their price target on shares of AMETEK from $260.00 to $291.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Truist Financial increased their price objective on shares of AMETEK from $303.00 to $316.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Robert W. Baird set a $275.00 target price on shares of AMETEK in a report on Wednesday, August 5th. Seaport Research Partners restated a “buy” rating and issued a $290.00 target price on shares of AMETEK in a research note on Wednesday, August 5th. Finally, KeyCorp upped their target price on AMETEK from $260.00 to $295.00 and gave the company an “overweight” rating in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $266.69.

AMETEK Stock Performance

Shares of NYSE AME traded up $7.75 during trading on Friday, reaching $241.99. The stock had a trading volume of 403,897 shares, compared to its average volume of 1,284,930. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.76 and a current ratio of 1.21. The stock has a market cap of $55.46 billion, a PE ratio of 35.37, a P/E/G ratio of 3.02 and a beta of 0.99. AMETEK has a one year low of $179.24 and a one year high of $261.16. The firm’s 50 day moving average price is $241.27 and its two-hundred day moving average price is $232.61.

AMETEK (NYSE:AME) last released its quarterly earnings data on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.10. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $1.95 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. The firm’s revenue was up 15.0% on a year-over-year basis. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. On average, research analysts forecast that AMETEK will post 8.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider David Hermance sold 6,608 shares of AMETEK stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $254.00, for a total value of $1,678,432.00. Following the sale, the insider directly owned 42,509 shares in the company, valued at $10,797,286. This trade represents a 13.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.54% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On AMETEK

Several large investors have recently made changes to their positions in AME. Frazier Financial Advisors LLC bought a new position in AMETEK in the 2nd quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new position in shares of AMETEK in the second quarter worth $25,000. Fiduciary Financial Advisors acquired a new position in shares of AMETEK during the second quarter valued at $27,000. MV Capital Management Inc. bought a new stake in shares of AMETEK during the fourth quarter valued at about $28,000. Finally, Brown Lisle Cummings Inc. raised its stake in shares of AMETEK by 878.6% during the first quarter. Brown Lisle Cummings Inc. now owns 137 shares of the technology company’s stock valued at $29,000 after purchasing an additional 123 shares in the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.

AMETEK Company Profile

AMETEK, Inc (NYSE: AME) is a diversified manufacturer of industrial technology products and solutions. The company develops equipment used to monitor, measure, test, control and analyze processes across a range of industrial and commercial applications.

AMETEK operates through two primary business groups: Electronic Instruments, which provides analytical, monitoring, testing and measurement equipment; and Electromechanical, which supplies automation systems, motors, power systems, aerospace and defense products, engineered materials and other specialized components.